Advanced glycation end products, diabetes, and the brain

Neurology

Volumn 77, Issue 14, 2011, Pages 1326-1327

  Coker, Laura H ^a   Wagenknecht, Lynne E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN; PENTOSIDINE;

ALZHEIMER DISEASE; COGNITION; COGNITIVE DEFECT; EDITORIAL; GLYCATION; HUMAN; MENTAL PERFORMANCE; MULTIINFARCT DEMENTIA; NERVE DEGENERATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TISSUE DISTRIBUTION; AGING; DIABETES MELLITUS; FEMALE; MALE; NOTE; PHYSIOLOGY; URINE;

AGING; COGNITION DISORDERS; DIABETES MELLITUS; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE;

EID: 82255182349     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318231532b     Document Type: Editorial

References (10)

1. Reijmer YD, van den Berg E, de Bresser J, et al. Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors. Diabetes Metab Res Rev 2011;27:195-202.
2. Semba RD, Nicklett EJ, Ferrucci L. Does accumulation of advanced glycation end products contribute to the aging phenotype? J Gerontol A Biol Sci Med Sci 2010;65A:963-975.
3. Uribarri J, Woodruff S, Goodman S, et al. Advanced glycation end products in foods and practical guide in their reduction in the diet. J Am Diet Assoc 2010;110:911-916.
4. Vlassara H, Striker G. Glycotoxins in the diet promote diabetes and diabetic complications. Curr Diabetes Rep 2007;7:235-241. (Pubitemid 46951921)
5. Valente T, Gella A, Fernandez-Busquets X, Unzeta M, Durany N. Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus. Neurobiol Dis 2010;37:67-76.
6. Southern L, Williams J, Esiri MM. Immunohistochemical study of N-epsilon-carboxymethyl lysine (CML) in human brain: relation to vascular dementia. BMC Neurol 2007; 7:35.
7. Ulrich P, Cerami A. Protein glycation, diabetes, and aging. Recent Prog Horm Res 2001;56:1-21.
8. Castellani RJ, Harris PLR, Sayre L, et al. Active glycation in neurofibrillary pathology of Alzheimer disease: N-epsilon-carboxymethyl lysine and hexitol lysine. Free Radic Biol Med 2001;31:175-180. (Pubitemid 32607584)
9. Schmidt AM, Sahagan B, Nelson RB, Selmer J, Rothlelin R, Bell JM. The role of RAGE in amyloid-beta peptidemediated pathology in Alzheimer's disease. Curr Opin Investig Drugs 2009;10:672-680.
10. Yaffe K, Lindquist K, Schwartz AV, et al. Advanced glycation end product level, diabetes, and accelerated cognitive aging. Neurology 2011;77:1351-1356.